lobbying_activities: 2071442

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2071442	33d51643-eb27-47be-a3c8-f541a55ef119	Q4	BLUECROSS BLUESHIELD OF TENNESSEE	6440	BLUECROSS BLUESHIELD OF TENNESSEE	2017	fourth_quarter	PHA	General pharmacy and pharmaceutical issues; Opioid Abuse; prescription drug pricing; generic drug issues; HR2051; HR22312.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		30000	0	0	2018-01-19T11:21:27.633000-05:00